-+ 0.00%
-+ 0.00%
-+ 0.00%

DongKook Pharmaceutical Announces Extraordinary Shareholders Meeting

PUBT·11/12/2026 10:11:14
DongKook Pharmaceutical Announces Extraordinary Shareholders Meeting
  • DongKook Pharmaceutical will hold an extraordinary shareholders meeting on November 27, 2026, at its Cheongdam Building auditorium in Seoul.
  • Shareholders will vote on amendments to rename the company DK Centellian, effective November 27, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DongKook Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261112000649), on November 12, 2026, and is solely responsible for the information contained therein.